← Eichor
Condition: Erdheim Chester Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Erdheim Chester Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT03329274Histiocytic Disorder Follow-up Study
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05915208Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · 2 location(s) · Mayo Clinic · NCT06712810International Rare Histiocytic Disorders Registry (IRHDR)
Phase N/A · 15 location(s) · The Hospital for Sick Children · NCT02285582DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Phase 2 · 12 location(s) · Carl Allen · NCT04079179Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT03990428ECD-Score: a Study on Erdheim-Chester Disease
Phase N/A · 7 location(s) · Meyer Children's Hospital IRCCS · NCT07454343In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
EARLY_Phase 1 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT05093335
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.